Ming‐Lung Yu
- Hepatology top 0.05%
- Hepatitis C virus research 303
- Liver Disease and Transplantation 35
- Hepatocellular Carcinoma Treatment and Prognosis 30
- Liver Diseases and Immunity 17
- Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment 307
- Hepatitis B Virus Studies 233
-
- Diet, Metabolism, and Disease 17
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 20
- Infectious Diseases top 2%
Ming‐Lung Yu
471 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Hepatology 7.4k
- Epidemiology 7.7k
- Endocrinology, Diabetes and Metabolism 810
- Rheumatology 614
- Infectious Diseases 707
Countries citing papers authored by Ming‐Lung Yu
This map shows the geographic impact of Ming‐Lung Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Lung Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Lung Yu more than expected).
Fields of papers citing papers by Ming‐Lung Yu
This network shows the impact of papers produced by Ming‐Lung Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Lung Yu. The network helps show where Ming‐Lung Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming‐Lung Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 22 | |
| 14 | 2018 | 8 | |
| 15 | 2016 | 26 | |
| 16 | 2015 | 21 | |
| 17 | 2014 | 16 | |
| 18 | 2013 | 54 | |
| 19 | 2007 | 22 | |
| 20 | 2006 | 19 |
About Ming‐Lung Yu
Ming‐Lung Yu is a scholar working on Hepatology, Epidemiology, Endocrinology, Diabetes and Metabolism, Rheumatology and Infectious Diseases, having authored 490 papers that have together received 10.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (307 papers), Hepatitis C virus research (303 papers), Hepatitis B Virus Studies (233 papers), Liver Disease and Transplantation (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Systemic Lupus Erythematosus Research (20 papers), Liver Diseases and Immunity (17 papers) and Diet, Metabolism, and Disease (17 papers). The work is most often cited by research in Hepatology (7.4k citations), Epidemiology (7.7k citations), Endocrinology, Diabetes and Metabolism (810 citations), Rheumatology (614 citations) and Infectious Diseases (707 citations). Ming‐Lung Yu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Wan‐Long Chuang, Chia‐Yen Dai, Jee‐Fu Huang, Zu‐Yau Lin, Chung‐Feng Huang, Liang‐Yen Wang, Shinn‐Cherng Chen, Ming‐Lun Yeh, Ming‐Yen Hsieh and Ming‐Yuh Hsieh. Their work appears in journals such as Journal of Gastroenterology and Hepatology, PLoS ONE, Hepatology International, Journal of Hepatology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.